Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 5
2005 5
2006 3
2007 9
2008 7
2009 2
2010 2
2011 4
2012 4
2013 2
2014 5
2015 3
2016 5
2017 2
2018 3
2019 4
2020 5
2021 4
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S. Toi M, et al. Among authors: imoto s. Lancet Oncol. 2021 Jan;22(1):74-84. doi: 10.1016/S1470-2045(20)30534-9. Lancet Oncol. 2021. PMID: 33387497 Clinical Trial.
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma.
Aihara T, Kumamaru H, Ishitobi M, Miyashita M, Miyata H, Tamura K, Yoshida M, Ogo E, Nagahashi M, Asaga S, Kojima Y, Kadoya T, Aogi K, Niikura N, Iijima K, Hayashi N, Kubo M, Yamamoto Y, Takeuchi Y, Imoto S, Jinno H. Aihara T, et al. Among authors: imoto s. Breast Cancer Res Treat. 2022 Dec;196(3):635-645. doi: 10.1007/s10549-022-06749-3. Epub 2022 Oct 23. Breast Cancer Res Treat. 2022. PMID: 36273358
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Takada M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Ohno S, Ishiguro H, Kanbayashi C, Miyamoto T, Hagiwara Y, Toi M. Takada M, et al. Among authors: imoto s. Breast Cancer Res Treat. 2023 Dec;202(3):485-496. doi: 10.1007/s10549-023-07099-4. Epub 2023 Sep 7. Breast Cancer Res Treat. 2023. PMID: 37676450 Free PMC article.
The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future.
Mathelin C, Lodi M, Alghamdi K, Arboleda-Osorio B, Avisar E, Anyanwu S, Boubnider M, Costa MM, Elder E, Elonge T, Gebrim L, Hao X, Imoto S, Meka E, Mouelle M, Mundinger A, Ostapenko V, Özbaş S, Özmen T, Özmen V, Pienkowski T, Sarria G, Selim A, Semiglazov V, Schneebaum S. Mathelin C, et al. Among authors: imoto s. Eur J Breast Health. 2022 Jul 1;18(3):205-221. doi: 10.4274/ejbh.galenos.2022.2022-4-3. eCollection 2022 Jul. Eur J Breast Health. 2022. PMID: 35855198 Free PMC article.
Correction: Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry.
Esgueva AJ, Noordhoek I, Kranenbarg EM, Espinosa-Bravo M, Mátrai Z, Zhygulin A, Irmejs A, Mavioso C, Meani F, González E, Özdemir M, Allweis T, Rogowski K, Dos Santos CR, Mora H, Ponzone R, Samorani D, van de Velde C, Audisio RA, Rubio IT; INSPIRE collaborators group. Esgueva AJ, et al. Ann Surg Oncol. 2022 Sep;29(9):5828. doi: 10.1245/s10434-022-11812-w. Ann Surg Oncol. 2022. PMID: 35486268 No abstract available.
Annual report of the Japanese Breast Cancer Registry for 2017.
Hayashi N, Kumamaru H, Isozumi U, Aogi K, Asaga S, Iijima K, Kadoya T, Kojima Y, Kubo M, Miyashita M, Miyata H, Nagahashi M, Niikura N, Ogo E, Tamura K, Tanakura K, Yamamoto Y, Yoshida M, Imoto S, Jinno H. Hayashi N, et al. Among authors: imoto s. Breast Cancer. 2020 Sep;27(5):803-809. doi: 10.1007/s12282-020-01139-3. Epub 2020 Jul 24. Breast Cancer. 2020. PMID: 32710374
Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
Ito T, Oura S, Nagamine S, Takahashi M, Yamamoto N, Yamamichi N, Earashi M, Doihara H, Imoto S, Mitsuyama S, Akazawa K. Ito T, et al. Among authors: imoto s. Clin Breast Cancer. 2018 Aug;18(4):e495-e500. doi: 10.1016/j.clbc.2017.09.007. Epub 2017 Sep 25. Clin Breast Cancer. 2018. PMID: 29079443 Free article.
85 results